Calumet delivered a quarter that left Street estimates far behind. On Earnings Whispers' normalized basis, the company earned $4.65 per share against a $1.21 consensus, a 284.3% surprise. Earnings grew 2314.3% year over year. Revenue of $1.683 billion beat the $1.24 billion consensus by 35.7% and rose 56.1%. Adjusted EBITDA with tax attributes reached a record $347.2 million, roughly double the second quarter's $175 million and nearly four times the year-ago $92.5 million. The central tension is that much of this earnings power comes from an unusually tight specialty market that management openly says will normalize. That turns this into a story about how fast Calumet can convert a cyclical windfall into a permanently stronger balance sheet.

The quality of the beat deserves some scrutiny on the GAAP side. Reported basic EPS was $2.91, down from $3.61 a year ago. Net income was shaped by two non-cash items that pulled in opposite directions:

• a $113.8 million unrealized derivative loss;
• $176.7 million of non-cash RINs-related gains.

Equity-based compensation also jumped to $38.0 million from $5.9 million. The operating improvement itself, however, is unambiguous. Specialty Products & Solutions adjusted EBITDA rose to $248.1 million from $80.2 million. Segment margin was 23.2% versus 11.8%, and adjusted gross profit per barrel more than tripled to $48.04. Production volumes were actually slightly lower, so this was a pricing and margin story, not a volume story. Management attributed it to a global specialty shortage, lasting supply-chain disruptions, and commercial execution.

The sequential trajectory is what makes the quarter striking. SPS EBITDA has climbed from $44.3 million in the first quarter to $161.7 million in the second and $248.1 million now. Specialty margins topped $108 per barrel, versus $54 per barrel in the first quarter. Montana Renewables added a second engine. MRL posted record adjusted EBITDA with tax attributes of $80.4 million, or $1.86 per gallon, in its first full quarter since the SET2 RVO, up from $17 million in the second quarter. The Montana refinery (CMR) contributed $40.8 million. Management said fourth-quarter specialty demand is holding and framed the supply shortfall as a "2027 and beyond" story. Even so, it conceded that roughly $250 million SPS quarters are not the new baseline once global base oil capacity returns. Performance Brands remains the weak spot: EBITDA was $9.1 million versus $13.2 million, and that figure included $7.0 million of insurance proceeds while price increases lag feedstock costs.

The most durable development may be the balance sheet. Calumet has retired roughly $265 million of high-cost debt since July, saving about $26 million in annual interest. Consolidated net leverage is now about 3.0x, compared with 4.9x at year-end 2025, and the 2029 notes become callable at par in January. The MaxSAF reconfiguration is finalized: an amended DOE loan guarantee delivers about 70% of the original benefit, roughly $137 million, for less than 15% of the originally planned Phase II capital. The SAF ramp targets an 80 million gallon run rate by year-end and 200 million gallons in 2028. That year-end target sits at the low end of the prior 80-100 million range, and the 120-150 million gallon milestone has slipped from spring to end-2027. Bears also have legitimate ammunition:

• the fourth quarter carries heavy downtime from the Shreveport turnaround in October and the MRL tie-in for most of November;
• catalyst damage from the April outage still limits MRL rates;
• Warburg's preferred return rises to 11.5% PIK;
• stockholders' equity remains negative at -$870.7 million.

The market setup is more complicated than the surprise implies. Shares ran to a 52-week high of $59.87 on September 21 as the specialty boom became visible. They then gave back most of that spike, closing at $43.35 before the report. That is 27.6% below the high and only 6.1% above the open following the August report. The stock still sits about 11% above its 200-day moving average, so the longer-term trend has improved even as the fall pullback signals investor doubts about sustainability. Investor sentiment moved from slightly negative (-0.08) to modestly positive (0.16) ahead of the release. That is a meaningful improvement, but hardly euphoric.

The bottom line is that Calumet posted a record quarter that overwhelmed expectations and, more importantly, used the windfall to cut leverage sharply and de-risk its SAF growth plan. Investors now have to weigh a weaker, downtime-heavy fourth quarter and management's own warning that peak specialty margins will fade. Lasting value will depend on whether the stronger balance sheet holds after the cycle turns.